Evidence supporting a rote for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia -: Young Investigator Award

被引:283
作者
Chaiworapongsa, T
Romero, R
Espinoza, J
Bujoid, E
Kim, YM
Goçalves, LF
Gomez, R
Edwin, S
机构
[1] NICHD, Perinatol Res Branch, NIH, DHHS, Bethesda, MD USA
[2] Wayne State Univ, Hutzel Hosp, Dept Obstet & Gynecol, Detroit, MI 48202 USA
[3] Hosp Dr Sotero del Rio, Dept Obstet & Gynecol, Puente Alto, Chile
关键词
preeclampsia; soluble vascular endothelial growth factor receptor 1; early-onset preeclampsia; vascular endothelial growth factor;
D O I
10.1016/j.ajog.2004.03.043
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Soluble vascular endothelial growth factor receptor I (sVEGFR-1), which antagonizes VEGF functions, has been implicated in the pathophysiology of preeclampsia. The purpose of this study was to determine whether preeclampsia is associated with a change in the plasma concentration of sVEGFR-1, and, if so, whether such a change is correlated with the severity of the disease. Methods: A cross-sectional study was conducted to determine the concentrations of sVEGFR-1 in plasma obtained from normal pregnant women (n = 61) and patients with preeclampsia (n = 6 1). Plasma concentrations of sVEGFR-1 were determined by enzyme-linked immunoassay. Results: Preeclampsia had a higher median plasma concentration of sVEGFR-1 than normal pregnancy (P < .001). The median plasma concentration of sVEGFR-1 was higher in early-onset (less than or equal to 34 weeks) than late-onset ( > 34 weeks) preeclampsia (P = .005), and higher in severe than in mild preeclampsia (P = .002). In normal pregnancy, there was a correlation between plasma concentration of sVEGFR-1 and gestational age (r = 0.5; P < .001). In contrast, there was a negative correlation between plasma concentration of sVEGFR-1 and gestational age at the onset of preeclampsia (r = -0.5; P < .001). Conclusion: Preeclampsia is associated with an increased plasma sVEGFR-1 concentration. The elevation of sVEGFR-1 concentration is correlated with the severity of the disease. These observations suggest the participation of VEGF and its soluble receptor in the pathophysiology of preeclampsia. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1541 / 1547
页数:7
相关论文
共 25 条
  • [1] COLOCALIZATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS FLT-1 RECEPTOR IN HUMAN PLACENTA
    AHMED, A
    LI, XF
    DUNK, C
    WHITTLE, MJ
    RUSHTON, DI
    ROLLASON, T
    [J]. GROWTH FACTORS, 1995, 12 (03) : 235 - 243
  • [2] Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors
    Barleon B.
    Reusch P.
    Totzke F.
    Herzog C.
    Keck C.
    Martiny-Baron G.
    Marmé D.
    [J]. Angiogenesis, 2001, 4 (2) : 143 - 154
  • [3] Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance
    Bosio, PM
    Wheeler, T
    Anthony, F
    Conroy, R
    O'Herlihy, C
    McKenna, P
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 184 (02) : 146 - 152
  • [4] VASCULAR ENDOTHELIAL GROWTH-FACTOR RECEPTOR LOCALIZATION AND ACTIVATION IN HUMAN TROPHOBLAST AND CHORIOCARCINOMA CELLS
    CHARNOCKJONES, DS
    SHARKEY, AM
    BOOCOCK, CA
    AHMED, A
    PLEVIN, R
    FERRARA, N
    SMITH, SK
    [J]. BIOLOGY OF REPRODUCTION, 1994, 51 (03) : 524 - 530
  • [5] A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation
    Clark, DE
    Smith, SK
    He, YL
    Day, KA
    Licence, DR
    Corps, AN
    Lammoglia, R
    Charnock-Jones, DS
    [J]. BIOLOGY OF REPRODUCTION, 1998, 59 (06) : 1540 - 1548
  • [6] Conrad KP, 1997, AM J REPROD IMMUNOL, V37, P240
  • [7] Etiology and pathogenesis of preeclampsia: Current concepts
    Dekker, GA
    Sibai, BM
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (05) : 1359 - 1375
  • [8] The biology of VEGF and its receptors
    Ferrara, N
    Gerber, HP
    LeCouter, J
    [J]. NATURE MEDICINE, 2003, 9 (06) : 669 - 676
  • [9] Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes - Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia
    Gerber, HP
    Condorelli, F
    Park, J
    Ferrara, N
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (38) : 23659 - 23667
  • [10] Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase Akt signal transduction pathway -: Requirement for Flk-1/KDR activation
    Gerber, HP
    McMurtrey, A
    Kowalski, J
    Yan, MH
    Keyt, BA
    Dixit, V
    Ferrara, N
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (46) : 30336 - 30343